Skip to main content
Erschienen in: Osteoporosis International 8/2017

13.04.2017 | Original Article

Oral contraceptive use and fracture risk—a retrospective study of 12,970 women in the UK

verfasst von: S. Dombrowski, L. Jacob, P. Hadji, K. Kostev

Erschienen in: Osteoporosis International | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

In the present retrospective case-control study, we compared 6485 women with fractures and 6485 women without fractures from 135 general practitioner offices in the UK. Women without bone fractures were statistically more likely to have been exposed to oral contraception, depending on their age and therapy duration.

Introduction

The aim of this analysis was to compare the risk of bone fracture in women using hormonal contraception with that in women who have never used hormonal contraception.

Methods

A total of 6485 women (mean age 37.8 years) with an initial diagnosis of fracture between January 2010 and December 2015 were identified in 135 doctors’ offices in the UK Disease Analyzer database. In this nested case-control study, each case with a fracture was matched (1:1) to a control without a fracture for age, index year, and follow-up time. In total, 12,970 individuals were available for analysis. The main outcome of the study was the risk of fracture as a function of combined oral contraceptive (OC) therapy. Multivariate logistic regression models were used to determine the effect of OC therapy and its duration on the risk of fracture in the entire population and in four age-specific subgroups.

Results

Women without bone fractures were significantly more likely to have used oral contraception (OR 0.81). The usage of oral contraception was associated with a significantly lower risk of bone fracture (OR 0.81, 95% CI 0.74–0.90). This effect was strongest in the age groups 18–25 and 26–35 and in patients with an OC treatment duration of more than 1 year.

Conclusions

The present study revealed that women without bone fractures were significantly more likely to have had exposure to combined oral contraception, especially where the duration of intake was at least 5 years.
Literatur
1.
Zurück zum Zitat The Family Planning Association (2007) Contraception: patterns of use factsheet. Accessed on 11/10/2016 The Family Planning Association (2007) Contraception: patterns of use factsheet. Accessed on 11/10/2016
4.
Zurück zum Zitat Dinger J, Bardenheuer K, Heinemann K (2014) Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception 89:253–263. doi:10.1016/j.contraception.2014.01.023 CrossRefPubMed Dinger J, Bardenheuer K, Heinemann K (2014) Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception 89:253–263. doi:10.​1016/​j.​contraception.​2014.​01.​023 CrossRefPubMed
7.
Zurück zum Zitat Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM (2012) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev. doi:10.1002/14651858.CD009849.pub2 Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM (2012) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev. doi:10.​1002/​14651858.​CD009849.​pub2
8.
Zurück zum Zitat Caserta D, Ralli E, Matteucci E, Bordi G, Mallozzi M, Moscarini M (2014) Combined oral contraceptives: health benefits beyond contraception. Panminerva Med 56:233–244PubMed Caserta D, Ralli E, Matteucci E, Bordi G, Mallozzi M, Moscarini M (2014) Combined oral contraceptives: health benefits beyond contraception. Panminerva Med 56:233–244PubMed
11.
Zurück zum Zitat Kuohung W, Borgatta L, Stubblefield P (2000) Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 61:77–82CrossRefPubMed Kuohung W, Borgatta L, Stubblefield P (2000) Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 61:77–82CrossRefPubMed
12.
Zurück zum Zitat Herrmann M, Seibel MJ (2010) The effects of hormonal contraceptives on bone turnover markers. Clin Endocrinol 72:571–583CrossRef Herrmann M, Seibel MJ (2010) The effects of hormonal contraceptives on bone turnover markers. Clin Endocrinol 72:571–583CrossRef
13.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2006) Oral contraceptive use and risk of fractures. Contraception 73:571–576CrossRefPubMed Vestergaard P, Rejnmark L, Mosekilde L (2006) Oral contraceptive use and risk of fractures. Contraception 73:571–576CrossRefPubMed
14.
Zurück zum Zitat Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626CrossRefPubMed Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626CrossRefPubMed
15.
Zurück zum Zitat Kyvernitakis I, Kostev K, Nassour T, Thomasius F, Hadji P (2016) The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. Osteoporos Int. doi:10.1007/s00198–016–3714-4 Kyvernitakis I, Kostev K, Nassour T, Thomasius F, Hadji P (2016) The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. Osteoporos Int. doi:10.​1007/​s00198–016–3714-4
16.
Zurück zum Zitat Pscherer S, Kostev K, Dippel FW, Rathmann W (2016) Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care. Diabetes Metab Syndr Obes Targets Ther 9:17–23. doi:10.2147/DMSO.S101370 Pscherer S, Kostev K, Dippel FW, Rathmann W (2016) Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care. Diabetes Metab Syndr Obes Targets Ther 9:17–23. doi:10.​2147/​DMSO.​S101370
18.
Zurück zum Zitat Schimdt N, Jacob L, Coleman R, Kostev K, Hadji P (2016) The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom. Breast Cancer Res Treat 155:151–157. doi:10.1007/s10549-015-3661-3 CrossRefPubMed Schimdt N, Jacob L, Coleman R, Kostev K, Hadji P (2016) The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom. Breast Cancer Res Treat 155:151–157. doi:10.​1007/​s10549-015-3661-3 CrossRefPubMed
20.
Zurück zum Zitat Fitzpatrick LA (2006) Estrogen therapy for postmenopausal osteoporosis. Arq Bras Endocrinol Metabol 50:705–719CrossRefPubMed Fitzpatrick LA (2006) Estrogen therapy for postmenopausal osteoporosis. Arq Bras Endocrinol Metabol 50:705–719CrossRefPubMed
21.
Zurück zum Zitat Corson SL (1993) Oral contraceptives for the prevention of osteoporosis. J Reprod Med 38:1015–1020PubMed Corson SL (1993) Oral contraceptives for the prevention of osteoporosis. J Reprod Med 38:1015–1020PubMed
23.
Zurück zum Zitat Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB (2005) Prior oral contraception and postmenopausal fracture: a Women’s Health Initiative observational cohort study. Fertil Steril 84(2):374–383CrossRefPubMed Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB (2005) Prior oral contraception and postmenopausal fracture: a Women’s Health Initiative observational cohort study. Fertil Steril 84(2):374–383CrossRefPubMed
26.
Zurück zum Zitat Marley WD, Kelly G, Thompson NW (2015) Alcohol-related fracture admissions: a retrospective observational study. Ulster Med J 84:94–97PubMedPubMedCentral Marley WD, Kelly G, Thompson NW (2015) Alcohol-related fracture admissions: a retrospective observational study. Ulster Med J 84:94–97PubMedPubMedCentral
28.
Zurück zum Zitat Jagielska GW, Przedlacki J, Bartoszewicz Z, Racicka E (2016) Bone mineralization disorders as a complication of anorexia nervosa—etiology, prevalence, course and treatment. Psychiatr Pol 50:509–520. doi:10.12740/PP/59289 CrossRefPubMed Jagielska GW, Przedlacki J, Bartoszewicz Z, Racicka E (2016) Bone mineralization disorders as a complication of anorexia nervosa—etiology, prevalence, course and treatment. Psychiatr Pol 50:509–520. doi:10.​12740/​PP/​59289 CrossRefPubMed
30.
Zurück zum Zitat Fan H-C, Lee H-S, Chang K-P, Lee Y-Y, Lai H-C, Hung P-L, Lee H-F, Chi C-S (2016) The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci 17:1242. doi:10.3390/ijms17081242 Fan H-C, Lee H-S, Chang K-P, Lee Y-Y, Lai H-C, Hung P-L, Lee H-F, Chi C-S (2016) The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci 17:1242. doi:10.​3390/​ijms17081242
34.
Zurück zum Zitat Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D (2015 Feb) Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. Osteoporos Int 26(2):827–833. doi:10.1007/s00198-014-2986-9 CrossRefPubMed Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C, Diez-Perez A, Prieto-Alhambra D (2015 Feb) Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. Osteoporos Int 26(2):827–833. doi:10.​1007/​s00198-014-2986-9 CrossRefPubMed
Metadaten
Titel
Oral contraceptive use and fracture risk—a retrospective study of 12,970 women in the UK
verfasst von
S. Dombrowski
L. Jacob
P. Hadji
K. Kostev
Publikationsdatum
13.04.2017
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2017
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-4036-x

Weitere Artikel der Ausgabe 8/2017

Osteoporosis International 8/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.